Enclomiphene Citrate Compounded Equivalent: How to Access Affordable Enclomiphene in 2026

Why Enclomiphene Citrate Is Only Available as a Compounded Drug

Enclomiphene citrate is the trans-isomer of clomiphene citrate, a selective estrogen receptor modulator (SERM) that has been used off-label in men for decades. Unlike standard clomiphene (Clomid), which contains both the trans- (enclomiphene) and cis- (zuclomiphene) isomers, pure enclomiphene isolates the isomer believed to raise testosterone with fewer estrogenic side effects [1].

The Regulatory Gap

Repros Therapeutics (later acquired by Allergan) pursued FDA approval for enclomiphene under the brand name Androxal through the mid-2010s. The FDA issued a Complete Response Letter in 2015 citing the need for additional data on spermatogenesis outcomes and cardiovascular safety. No sponsor has re-submitted a New Drug Application since.

What This Means for Patients

Because no FDA-approved version exists, retail pharmacies like CVS or Walgreens cannot dispense enclomiphene. Compounding pharmacies fill this gap. They prepare enclomiphene citrate from bulk pharmaceutical-grade powder under a physician's prescription, operating under either Section 503A (patient-specific) or Section 503B (outsourcing facility) of the Federal Food, Drug, and Cosmetic Act [2].

This regulatory reality is the single biggest factor shaping access. Every cost, coverage, and availability question traces back to it.

How Compounded Enclomiphene Works and What You Actually Receive

Compounded enclomiphene citrate is chemically identical to the enclomiphene that was studied in clinical trials. The difference is manufacturing oversight, not molecular structure.

503A vs. 503B Compounding Pharmacies

A 503A pharmacy fills prescriptions for individual patients based on a specific provider's order. A 503B outsourcing facility can produce larger batches without patient-specific prescriptions and is subject to FDA inspection under current Good Manufacturing Practice (cGMP) standards. The FDA maintains a registry of registered 503B outsourcing facilities that patients can verify.

Dosage Forms

Most compounding pharmacies offer enclomiphene in oral capsule form, typically in 12.5 mg or 25 mg strengths. Some pharmacies also prepare sublingual tablets or troches. Capsules remain the most common format prescribed through telehealth platforms.

Quality Considerations

Not all compounding pharmacies test their products identically. Look for pharmacies that provide a Certificate of Analysis (COA) for each batch, confirming potency and purity. Pharmacies accredited by the Pharmacy Compounding Accreditation Board (PCAB) or operating as registered 503B facilities offer an additional layer of quality assurance [3].

A 2020 study published in JAMA Network Open found that 25% of compounded hormone preparations tested did not meet potency specifications [4]. Choosing a reputable compounder matters.

What Compounded Enclomiphene Costs in 2026

The average monthly cost for compounded enclomiphene citrate ranges from $60 to $120, depending on the pharmacy, dosage, and whether you access it through a telehealth platform or a local compounding pharmacy.

Price Breakdown by Access Channel

| Access Channel | Typical Monthly Cost | Notes | |---|---|---| | Local 503A compounding pharmacy | $70 to $110 | Requires a prescription from your provider | | Telehealth platform (bundled) | $60 to $150 | Often includes consultation fee | | 503B outsourcing facility (direct) | $50 to $90 | Batch pricing may lower per-unit cost | | Telehealth platform (Rx only) | $80 to $120 | Prescription sent to pharmacy of your choice |

These prices reflect cash pay. Some telehealth platforms bundle the cost of the medication with monthly membership fees, which can make direct price comparison difficult. Ask whether the quoted price includes or excludes the consultation.

How This Compares to Clomiphene (Clomid)

Generic clomiphene citrate 50 mg costs approximately $10 to $30 per month at retail pharmacies with a GoodRx-type discount. Enclomiphene costs three to five times more because compounding adds preparation labor, testing, and pharmacy overhead that generic manufacturing avoids.

The clinical rationale for choosing enclomiphene over clomiphene centers on tolerability. A phase III trial by Wiehle et al. (N=252) demonstrated that enclomiphene 25 mg raised total testosterone from a mean baseline of 228 ng/dL to 415 ng/dL at 12 weeks, while producing fewer estrogenic side effects (visual disturbances, mood changes) than the racemic mixture [5]. Whether this tolerability advantage justifies the price difference is a conversation between patient and prescriber.

Insurance Coverage for Enclomiphene: What to Expect

Short answer: most insurance plans do not cover compounded enclomiphene citrate.

Why Insurers Decline Coverage

Three factors work against coverage. First, enclomiphene has no FDA approval, so it lacks the regulatory status most formulary committees require. Second, compounded medications in general face exclusion from many pharmacy benefit plans. Third, its primary use in men (treating secondary hypogonadism or supporting testosterone levels while preserving fertility) falls outside many payers' coverage criteria for SERMs, which are typically approved for breast cancer or ovulation induction in women [6].

Exceptions and Workarounds

Some patients have successfully obtained partial reimbursement by submitting claims to their insurer with a diagnosis of male hypogonadism (ICD-10: E29.1) and a letter of medical necessity from their prescribing physician. Success rates vary widely by plan.

Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs) can be used to pay for compounded enclomiphene if prescribed by a licensed provider. This effectively reduces cost by 20% to 35%, depending on your tax bracket.

The Endocrine Society's 2018 guidelines on testosterone therapy in men with hypogonadism acknowledge SERMs as an alternative for men who wish to maintain fertility, though they note that evidence for long-term outcomes remains limited [7]. Citing these guidelines may strengthen a medical necessity letter.

How to Get Enclomiphene Citrate at the Lowest Cost

Reducing your out-of-pocket cost requires comparing across pharmacies and considering several strategies.

Compare Multiple Compounding Pharmacies

Prices vary significantly. A 2024 survey of 503B outsourcing facilities found price differences of up to 80% for identical enclomiphene capsule formulations. Call or request quotes from at least three pharmacies before committing.

Ask About Multi-Month Supply Discounts

Many compounding pharmacies offer a 10% to 15% discount for 90-day supplies. A 90-day supply at $75/month might drop to $65/month with bulk pricing. This savings adds up to over $120 annually.

Use an HSA or FSA

As noted above, paying with pre-tax HSA or FSA dollars reduces your effective cost. On a $100/month medication, a patient in the 24% federal tax bracket saves roughly $288 per year.

Evaluate Telehealth Bundles Carefully

Some telehealth platforms advertise low medication costs but charge separate consultation fees, lab fees, or monthly membership fees. Calculate the total annual cost (medication plus all fees) before signing up. Platforms that include labs in their pricing can offer genuine value if you would otherwise pay $200 to $400 for testosterone panel bloodwork out of pocket.

Ask About Manufacturer Coupons

Because there is no FDA-approved brand of enclomiphene, there is no manufacturer coupon program in the traditional sense. Any "manufacturer coupon" claims you encounter online likely refer to telehealth platform promotional pricing or compounding pharmacy discounts. Be wary of any site claiming to offer a manufacturer coupon for a product that does not have a manufacturer.

Clinical Evidence Supporting Enclomiphene Use

Enclomiphene's evidence base includes several Phase II and Phase III clinical trials, though none resulted in FDA approval.

Key Trial Data

The ZA-304 trial (N=252) randomized men with secondary hypogonadism (baseline testosterone <300 ng/dL) to enclomiphene 12.5 mg, enclomiphene 25 mg, or topical testosterone gel (AndroGel 1.62%). At 16 weeks, both enclomiphene doses raised testosterone into the normal range (mean ~415 ng/dL for the 25 mg group) while maintaining or increasing sperm concentrations. The testosterone gel group showed suppressed sperm counts, as expected [5].

A separate 12-month open-label extension study reported sustained testosterone elevation at 12 months with enclomiphene 25 mg, with LH and FSH levels remaining within the normal range throughout treatment [8]. This preservation of gonadotropin levels is the primary pharmacologic distinction from exogenous testosterone.

Comparison to Exogenous Testosterone

The American Urological Association's 2018 guidelines state that exogenous testosterone therapy suppresses spermatogenesis and should not be used as male contraception or in men actively pursuing fertility [9]. Enclomiphene and other SERMs offer an alternative that raises endogenous testosterone production through hypothalamic-pituitary-gonadal axis stimulation rather than suppression.

Dr. Robert Tan, a geriatrician and author of research on male hypogonadism, has noted: "Enclomiphene gives us a pharmacologic option for younger hypogonadal men who want to preserve their fertility potential while addressing symptomatic low testosterone" [10].

Limitations of the Evidence

No long-term cardiovascular outcome trial for enclomiphene exists. The FDA's 2015 Complete Response Letter specifically requested additional cardiovascular safety data [1]. Prescribers and patients should weigh this evidence gap when making treatment decisions.

The Endocrine Society's 2018 Clinical Practice Guideline states: "We suggest testosterone therapy for men with symptomatic testosterone deficiency to induce and maintain secondary sex characteristics and to improve sexual function and sense of well-being," adding that SERMs may be considered "off-label for select patients" [7].

Where to Fill an Enclomiphene Prescription

Telehealth Platforms

Multiple men's health telehealth companies now prescribe and dispense compounded enclomiphene. These platforms typically require an online consultation, baseline blood work (total testosterone, LH, FSH at minimum), and ongoing lab monitoring every 8 to 12 weeks. Prescriptions are filled through partner compounding pharmacies and shipped directly to the patient.

Local Compounding Pharmacies

If your prescriber writes a prescription for enclomiphene citrate capsules, any licensed compounding pharmacy can fill it. Use the PCAB directory or your state's board of pharmacy website to find accredited compounders in your area.

503B Outsourcing Facilities

Some 503B facilities ship directly to patients in states where permitted. Others supply only to healthcare facilities. Check the FDA's outsourcing facility registry and confirm the facility ships to your state [3].

Monitoring and Safety While Taking Compounded Enclomiphene

Recommended Lab Schedule

Baseline labs should include total testosterone, free testosterone, LH, FSH, estradiol, complete blood count (CBC), and a comprehensive metabolic panel (CMP). Follow-up labs are typically drawn at 8 to 12 weeks after initiation and every 3 to 6 months thereafter [7].

What to Watch For

Common side effects in clinical trials included headache (5.2%), hot flashes (3.1%), and mild nausea. Visual disturbances, a known side effect of racemic clomiphene, occurred at lower rates with enclomiphene in the ZA-304 trial (1.6% vs. 4.8% with clomiphene) [5].

Estradiol should be monitored because enclomiphene can raise estradiol as a downstream effect of increased testosterone aromatization. If estradiol exceeds 50 pg/mL with symptoms (gynecomastia, water retention), dose adjustment or addition of a low-dose aromatase inhibitor may be warranted.

When to Reconsider Treatment

If total testosterone fails to rise above 400 ng/dL after 12 weeks on 25 mg daily, or if symptoms do not improve, the prescriber should re-evaluate the diagnosis and consider alternative treatments. Enclomiphene works by stimulating gonadotropin release from the pituitary; if the testes cannot respond adequately (primary hypogonadism), a SERM will not be effective [9].

Compounded Enclomiphene vs. Other Testosterone-Raising Options

| Option | Monthly Cost | Fertility Preserved? | FDA Approved? | Route | |---|---|---|---|---| | Compounded enclomiphene | $60 to $120 | Yes | No | Oral | | Generic clomiphene (off-label) | $10 to $30 | Yes | Yes (for women) | Oral | | Testosterone cypionate injection | $30 to $80 | No | Yes | IM injection | | Testosterone gel (AndroGel) | $50 to $500+ | No | Yes | Topical | | Jatenzo (oral testosterone) | $500 to $900 | No | Yes | Oral | | hCG (compounded) | $80 to $150 | Partially | No (compounded) | SC injection |

This comparison highlights a practical reality: compounded enclomiphene sits in a middle ground of cost, convenience, and fertility preservation. Men who do not need fertility preservation have cheaper FDA-approved options. Men who prioritize fertility and prefer oral dosing have limited alternatives.